Home LiteratureArticle Details
PMID: 16774939 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Frequent occurrence of uniparental disomy in colorectal cancer.

Carcinogenesis ·Vol. 28 ·No. 1 ·2007-01-00 ·Pages 38-48

Andersen CL, Wiuf C, Kruhøffer M, Korsgaard M, Laurberg S, Ørntoft TF

Abstract

We used SNP arrays to identify and characterize genomic alterations associated with colorectal cancer (CRC). Laser microdissected cancer cells from 15 adenocarinomas were investigated by Affymetrix Mapping 10K SNP arrays. Analysis of the data extracted from the SNP arrays revealed multiple regions with copy number alterations and loss of heterozygosity (LOH). Novel LOH areas were identified at chromosomes 13, 14 and 15. Combined analysis of the LOH and copy number data revealed genomic structures that could not have been identified analyzing either data type alone. Half of the identified LOH regions showed no evidence of a reduced copy number, indicating the presence of uniparental structures. The distribution of these structures was non-random, primarily involving 8q, 13q and 20q. This finding was supported by analysis of an independent set of array-based transcriptional profiles, consisting of 17 normal mucosa and 66 adenocarcinoma samples. The transcriptional analysis revealed an unchanged expression level in areas with intact copy number, including regions with uniparental disomy, and a reduced expression level in the LOH regions representing factual losses (including 5q, 8p and 17p). The analysis also showed that genes in regions with increased copy number (including 7p and 20q) were predominantly upregulated. Further analyses of the SNP data revealed a subset of the identified alterations to be specifically associated with TP53 inactivation (including 8q gain and 17p loss) and lymph node metastasis status (gain of 7q and 13q). Another subset of the identified alterations was shown to represent intratumor heterogeneity. In conclusion, we demonstrate that uniparental disomy is frequent in CRC, and identify genomic alterations associated with TP53 inactivation and lymph node status.

MeSH Terms
Adenocarcinoma/genetics Aged Aged, 80 and over Chromosome Mapping Chromosomes, Human/genetics Colon/metabolism,pathology Colorectal Neoplasms/genetics DNA, Neoplasm/genetics,metabolism Gene Dosage Genomics Humans In Situ Hybridization, Fluorescence Karyotyping Loss of Heterozygosity Lymphatic Metastasis/pathology Microsatellite Repeats Middle Aged Mucous Membrane/metabolism,pathology Nucleic Acid Hybridization Oligonucleotide Array Sequence Analysis Polymorphism, Single Nucleotide/genetics RNA, Messenger/genetics,metabolism RNA, Neoplasm/genetics,metabolism Reverse Transcriptase Polymerase Chain Reaction Tumor Suppressor Protein p53/genetics Uniparental Disomy/genetics
Chemicals
DNA, Neoplasm RNA, Messenger RNA, Neoplasm Tumor Suppressor Protein p53
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Andersen Claus Lindbjerg
Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby DK-8200, Aarhus N, Denmark.
Wiuf Carsten
Kruhøffer Mogens
Korsgaard Marianne
Laurberg Søren
Ørntoft Torben Falck
Article Info
Journal
Carcinogenesis
Abbr.
Carcinogenesis
ISSN
0143-3334
Published
2007-01-00
Epub
2006-00-13
Pages
38-48
Language
English
Region
England
NLM ID
8008055
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com